Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stents | 7 | 2013 | 121 | 1.450 |
Why?
|
| Coronary Angiography | 8 | 2014 | 150 | 1.380 |
Why?
|
| Myocardial Infarction | 6 | 2014 | 351 | 1.300 |
Why?
|
| Coronary Artery Disease | 5 | 2014 | 220 | 1.230 |
Why?
|
| Angioplasty, Balloon, Coronary | 4 | 2013 | 52 | 1.210 |
Why?
|
| Coronary Vessels | 4 | 2015 | 154 | 1.170 |
Why?
|
| Femoral Artery | 3 | 2013 | 58 | 1.110 |
Why?
|
| Atherectomy | 3 | 2012 | 11 | 1.110 |
Why?
|
| Aorta | 3 | 2014 | 124 | 0.860 |
Why?
|
| Acute Coronary Syndrome | 3 | 2014 | 64 | 0.790 |
Why?
|
| Intraoperative Complications | 2 | 2013 | 47 | 0.780 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2014 | 10 | 0.770 |
Why?
|
| Lower Extremity | 2 | 2014 | 85 | 0.750 |
Why?
|
| Hypertension, Pulmonary | 2 | 2021 | 34 | 0.750 |
Why?
|
| Percutaneous Coronary Intervention | 4 | 2015 | 291 | 0.730 |
Why?
|
| Middle Aged | 22 | 2018 | 7496 | 0.710 |
Why?
|
| Troponin I | 2 | 2021 | 14 | 0.710 |
Why?
|
| Peripheral Arterial Disease | 3 | 2013 | 144 | 0.710 |
Why?
|
| Humans | 41 | 2021 | 29214 | 0.680 |
Why?
|
| Angioplasty, Balloon | 5 | 2013 | 21 | 0.670 |
Why?
|
| Anemia, Sickle Cell | 1 | 2021 | 39 | 0.660 |
Why?
|
| Male | 23 | 2021 | 14127 | 0.590 |
Why?
|
| Cardiac Catheterization | 3 | 2014 | 114 | 0.580 |
Why?
|
| Postoperative Complications | 2 | 2013 | 643 | 0.540 |
Why?
|
| Radiography, Interventional | 2 | 2014 | 15 | 0.520 |
Why?
|
| Female | 22 | 2021 | 15826 | 0.500 |
Why?
|
| Treatment Outcome | 10 | 2014 | 2443 | 0.490 |
Why?
|
| Equipment Failure | 2 | 2013 | 31 | 0.480 |
Why?
|
| Aneurysm, False | 2 | 2013 | 19 | 0.470 |
Why?
|
| Heart Rupture | 1 | 2015 | 1 | 0.470 |
Why?
|
| Papillary Muscles | 1 | 2015 | 15 | 0.460 |
Why?
|
| Aorta, Thoracic | 2 | 2015 | 55 | 0.440 |
Why?
|
| Intracranial Embolism | 1 | 2014 | 6 | 0.430 |
Why?
|
| Electrocardiography | 3 | 2015 | 398 | 0.430 |
Why?
|
| Radiation Exposure | 1 | 2014 | 17 | 0.430 |
Why?
|
| von Willebrand Disease, Type 2 | 1 | 2014 | 1 | 0.430 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 2014 | 5 | 0.420 |
Why?
|
| Renal Veins | 1 | 2014 | 7 | 0.420 |
Why?
|
| Oxymetazoline | 1 | 2014 | 2 | 0.410 |
Why?
|
| Renal Artery | 1 | 2014 | 15 | 0.410 |
Why?
|
| Nasal Decongestants | 1 | 2014 | 3 | 0.410 |
Why?
|
| Arteriovenous Malformations | 1 | 2014 | 16 | 0.410 |
Why?
|
| Torsades de Pointes | 1 | 2013 | 3 | 0.410 |
Why?
|
| Lidocaine | 1 | 2013 | 27 | 0.410 |
Why?
|
| Saphenous Vein | 1 | 2013 | 24 | 0.400 |
Why?
|
| Cardiac Tamponade | 1 | 2013 | 8 | 0.400 |
Why?
|
| Methadone | 1 | 2013 | 18 | 0.400 |
Why?
|
| Pheochromocytoma | 1 | 2013 | 9 | 0.400 |
Why?
|
| Hyperthyroidism | 1 | 2013 | 10 | 0.400 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2013 | 9 | 0.400 |
Why?
|
| Endocarditis, Bacterial | 1 | 2013 | 15 | 0.390 |
Why?
|
| Hematoma | 1 | 2013 | 26 | 0.390 |
Why?
|
| Impotence, Vasculogenic | 1 | 2013 | 1 | 0.390 |
Why?
|
| Heart Valve Diseases | 1 | 2013 | 27 | 0.390 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2013 | 44 | 0.390 |
Why?
|
| Syncope | 1 | 2013 | 10 | 0.390 |
Why?
|
| Myxoma | 1 | 2013 | 6 | 0.390 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2013 | 117 | 0.390 |
Why?
|
| Fibroma | 1 | 2013 | 6 | 0.390 |
Why?
|
| Iliac Artery | 1 | 2013 | 19 | 0.380 |
Why?
|
| Heart Neoplasms | 1 | 2013 | 17 | 0.380 |
Why?
|
| Device Removal | 1 | 2013 | 30 | 0.380 |
Why?
|
| Catheters | 1 | 2013 | 24 | 0.380 |
Why?
|
| Penis | 1 | 2013 | 17 | 0.380 |
Why?
|
| Vascular Fistula | 1 | 2012 | 3 | 0.380 |
Why?
|
| Ethanolamines | 1 | 2012 | 2 | 0.380 |
Why?
|
| Coronary Vasospasm | 1 | 2012 | 4 | 0.380 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2012 | 5 | 0.380 |
Why?
|
| Scimitar Syndrome | 1 | 2012 | 6 | 0.380 |
Why?
|
| Nitroglycerin | 1 | 2012 | 27 | 0.380 |
Why?
|
| Vascular Access Devices | 1 | 2012 | 4 | 0.380 |
Why?
|
| Fistula | 1 | 2012 | 17 | 0.380 |
Why?
|
| Benzopyrans | 1 | 2012 | 22 | 0.370 |
Why?
|
| Aneurysm, Ruptured | 1 | 2012 | 20 | 0.370 |
Why?
|
| Radiography | 4 | 2014 | 203 | 0.370 |
Why?
|
| Vasodilator Agents | 1 | 2012 | 79 | 0.370 |
Why?
|
| Heart Diseases | 1 | 2012 | 71 | 0.370 |
Why?
|
| Coronary-Subclavian Steal Syndrome | 1 | 2012 | 1 | 0.360 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2012 | 3 | 0.360 |
Why?
|
| Coronary Disease | 1 | 2012 | 120 | 0.360 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 90 | 0.360 |
Why?
|
| Subclavian Artery | 1 | 2012 | 14 | 0.360 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2012 | 15 | 0.360 |
Why?
|
| Atherosclerosis | 1 | 2013 | 97 | 0.360 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2012 | 7 | 0.360 |
Why?
|
| Carotid Stenosis | 2 | 2009 | 28 | 0.350 |
Why?
|
| Coronary Stenosis | 1 | 2012 | 20 | 0.350 |
Why?
|
| Shock, Cardiogenic | 1 | 2012 | 23 | 0.350 |
Why?
|
| Heparin | 1 | 2012 | 116 | 0.340 |
Why?
|
| Heart Failure | 1 | 2014 | 254 | 0.340 |
Why?
|
| Thrombosis | 1 | 2012 | 155 | 0.320 |
Why?
|
| Anticoagulants | 1 | 2012 | 302 | 0.300 |
Why?
|
| Spinal Fusion | 1 | 2012 | 157 | 0.300 |
Why?
|
| Endosonography | 1 | 2009 | 37 | 0.300 |
Why?
|
| Dextrocardia | 1 | 2008 | 1 | 0.290 |
Why?
|
| Situs Inversus | 1 | 2008 | 1 | 0.290 |
Why?
|
| Diagnosis, Differential | 3 | 2014 | 382 | 0.270 |
Why?
|
| Hydrogen Sulfide | 2 | 2018 | 33 | 0.230 |
Why?
|
| Adult | 7 | 2021 | 8131 | 0.230 |
Why?
|
| Ultrasonography | 3 | 2014 | 244 | 0.210 |
Why?
|
| Popliteal Artery | 2 | 2013 | 10 | 0.190 |
Why?
|
| Ischemia | 2 | 2014 | 83 | 0.190 |
Why?
|
| Aged | 6 | 2018 | 5648 | 0.190 |
Why?
|
| Sinus of Valsalva | 1 | 2002 | 13 | 0.190 |
Why?
|
| Coronary Artery Bypass | 2 | 2015 | 68 | 0.180 |
Why?
|
| Young Adult | 3 | 2014 | 2877 | 0.180 |
Why?
|
| Combined Modality Therapy | 2 | 2013 | 303 | 0.180 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 384 | 0.170 |
Why?
|
| Bilirubin | 1 | 2021 | 11 | 0.170 |
Why?
|
| Biomarkers | 2 | 2021 | 790 | 0.150 |
Why?
|
| Cystathionine gamma-Lyase | 1 | 2018 | 7 | 0.140 |
Why?
|
| Sulfides | 1 | 2018 | 40 | 0.130 |
Why?
|
| Pulmonary Edema | 1 | 2015 | 9 | 0.120 |
Why?
|
| Aortic Coarctation | 1 | 2015 | 21 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 34 | 0.110 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2013 | 37 | 0.110 |
Why?
|
| Aneurysm, Dissecting | 1 | 2014 | 12 | 0.110 |
Why?
|
| Viscera | 1 | 2014 | 18 | 0.110 |
Why?
|
| Retrospective Studies | 1 | 2021 | 2662 | 0.110 |
Why?
|
| Radiation Dosage | 1 | 2014 | 54 | 0.110 |
Why?
|
| Hypertension, Renal | 1 | 2014 | 6 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2014 | 70 | 0.100 |
Why?
|
| Heart Arrest | 1 | 2014 | 27 | 0.100 |
Why?
|
| Nasal Sprays | 1 | 2014 | 1 | 0.100 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2013 | 9 | 0.100 |
Why?
|
| Heart Aneurysm | 1 | 2013 | 11 | 0.100 |
Why?
|
| Anastomosis, Surgical | 1 | 2013 | 38 | 0.100 |
Why?
|
| Opiate Substitution Treatment | 1 | 2013 | 9 | 0.100 |
Why?
|
| Debridement | 1 | 2013 | 10 | 0.100 |
Why?
|
| Retroperitoneal Space | 1 | 2013 | 9 | 0.100 |
Why?
|
| Pneumothorax | 1 | 2013 | 15 | 0.100 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2013 | 26 | 0.100 |
Why?
|
| Cocaine | 1 | 2013 | 22 | 0.100 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2013 | 22 | 0.100 |
Why?
|
| Postpartum Period | 1 | 2013 | 79 | 0.100 |
Why?
|
| Fibrosis | 1 | 2013 | 145 | 0.100 |
Why?
|
| Nebivolol | 1 | 2012 | 1 | 0.100 |
Why?
|
| Brachial Artery | 1 | 2013 | 37 | 0.100 |
Why?
|
| Vascular Surgical Procedures | 1 | 2013 | 55 | 0.100 |
Why?
|
| Opioid-Related Disorders | 1 | 2013 | 44 | 0.090 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2013 | 25 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2013 | 64 | 0.090 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 36 | 0.090 |
Why?
|
| Vascular Calcification | 1 | 2012 | 20 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2013 | 68 | 0.090 |
Why?
|
| Aortic Valve | 1 | 2013 | 92 | 0.090 |
Why?
|
| Recurrence | 1 | 2013 | 328 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 2070 | 0.090 |
Why?
|
| Minoxidil | 1 | 2012 | 1 | 0.090 |
Why?
|
| Vertebral Artery | 1 | 2012 | 16 | 0.090 |
Why?
|
| Pericardial Effusion | 1 | 2012 | 12 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2014 | 632 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2012 | 123 | 0.090 |
Why?
|
| Time Factors | 2 | 2013 | 1619 | 0.090 |
Why?
|
| Ticlopidine | 1 | 2012 | 34 | 0.090 |
Why?
|
| Antihypertensive Agents | 1 | 2012 | 56 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 210 | 0.090 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 168 | 0.090 |
Why?
|
| Equipment Design | 1 | 2012 | 218 | 0.090 |
Why?
|
| Aspirin | 1 | 2012 | 125 | 0.080 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2012 | 191 | 0.080 |
Why?
|
| Risk Factors | 1 | 2014 | 2144 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 540 | 0.070 |
Why?
|
| Neck Dissection | 1 | 2007 | 2 | 0.060 |
Why?
|
| Ultrasonography, Doppler | 1 | 2007 | 22 | 0.060 |
Why?
|
| Adolescent | 1 | 2014 | 3255 | 0.060 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2006 | 9 | 0.060 |
Why?
|
| Diphosphonates | 1 | 2006 | 15 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2006 | 31 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2007 | 94 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 225 | 0.060 |
Why?
|
| Bone Density | 1 | 2006 | 101 | 0.060 |
Why?
|
| Radiography, Thoracic | 2 | 2015 | 13 | 0.050 |
Why?
|
| Stroke | 1 | 2007 | 261 | 0.050 |
Why?
|
| Coronary Circulation | 1 | 2003 | 30 | 0.050 |
Why?
|
| Echocardiography | 2 | 2014 | 110 | 0.050 |
Why?
|
| Angina, Unstable | 1 | 2003 | 19 | 0.050 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2002 | 8 | 0.050 |
Why?
|
| Bridged Bicyclo Compounds | 1 | 2018 | 21 | 0.030 |
Why?
|
| Biological Availability | 1 | 2018 | 44 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 485 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 82 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2018 | 188 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 119 | 0.030 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 1 | 2015 | 13 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2015 | 26 | 0.030 |
Why?
|
| African Americans | 1 | 2018 | 353 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 557 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2014 | 43 | 0.030 |
Why?
|
| Thrombectomy | 1 | 2013 | 30 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2013 | 53 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2013 | 153 | 0.020 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2012 | 2 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 70 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2006 | 18 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2006 | 233 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 614 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 56 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2003 | 40 | 0.010 |
Why?
|
| Exercise Test | 1 | 2003 | 249 | 0.010 |
Why?
|
| Length of Stay | 1 | 2003 | 248 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 686 | 0.010 |
Why?
|